Company intelligence / Profile preview

Romer Labs

Ownership: Private
Employees: ~243
Development stage: Commercial

Overview

Romer Labs provides commercialized innovative diagnostic solutions—test kits and analytical services—for detecting mycotoxins, food allergens, GMOs, microbial contaminants, veterinary drug residues, and other hazards in agricultural products. The company operates globally with six analytical labs across three continents and has been active for over 40 years.

Modalities: Antibody (used in test kits)Molecular recognition technology
Industry: Agriculture & AgTech

Partnerships

Not specifically listed. Historically part of Erber Group before acquisition by dsm-firmenich.

Beyond the preview

Go deeper on Romer Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Romer Labs.

Explore the full profile